Protalix BioTherapeutics (PLX) Total Debt (QoQ) (2011 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.83% |
| Dec 31, 2023 | 0.29% |
| Sep 30, 2021 | -94.25% |
| Jun 30, 2021 | 1.78% |
| Mar 31, 2021 | 1.74% |
| Mar 31, 2018 | 0.15% |
| Dec 31, 2017 | -42.02% |
| Sep 30, 2017 | 137.43% |
| Jun 30, 2017 | 0.00% |
| Mar 31, 2017 | -92.61% |
| Dec 31, 2016 | 1,252.55% |
| Sep 30, 2016 | 0.00% |
| Jun 30, 2016 | 0.00% |
| Mar 31, 2016 | 0.00% |
| Jun 30, 2013 | -86.07% |
| Mar 31, 2013 | -50.23% |
| Dec 31, 2012 | 94.17% |
| Sep 30, 2012 | -40.30% |
| Dec 31, 2011 | 38.58% |
| Sep 30, 2011 | 6.42% |